Von Willebrand factor and disease: a review for laboratory professionals

References

• Lenting PJ, Christophe OD, Denis CV. Von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends. Blood. 2015;125(13):2019–2028.
   PubMed Web of Science ®Google Scholar
• Zhou YF, Eng ET, Zhu J, et al. Sequence and structure relationships within von Willebrand factor. Blood. 2012;120(2):449–458.
   PubMed Web of Science ®Google Scholar
• Springer TA. Von Willebrand factor, Jedi knight of the bloodstream. Blood. 2014;124(9):1412–1425.
   PubMed Web of Science ®Google Scholar
• Löf A, Müller JP, Brehm MA. A biophysical view on von Willebrand factor activation. J Cell Physiol. 2018;233(2):799–810.
   PubMed Web of Science ®Google Scholar
• López JA, Andrews RK, Afshar-Kharghan V, et al. Bernard-Soulier syndrome. Blood. 1998;91(12):4397–4418.
   PubMed Web of Science ®Google Scholar
• Andrews RK, Gardiner EE, Shen Y, et al. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol. 2003;35(8):1170–1174.
   PubMed Web of Science ®Google Scholar
• Berntorp E. Erik von willebrand. Thromb Res. 2007;120(1):S3–S 4.
   PubMedGoogle Scholar
• Winter WE, Flax SD, Harris NS. Coagulation testing in the core laboratory. Lab Med. 2017;48(4):295–313.
   PubMed Web of Science ®Google Scholar
• Haley KM. Platelet disorders. Pediatr Rev. 2020;41(5):224–235.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063–2065.
   PubMed Web of Science ®Google Scholar
• Pipe SW, Montgomery RR, Pratt KP, et al. Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A. Blood. 2016;128(16):2007–2016.
   PubMed Web of Science ®Google Scholar
• Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 2009;23(4):177–189.
   PubMed Web of Science ®Google Scholar
• McCormack JJ, Lopes da Silva M, Ferraro F, et al. Weibel-Palade bodies at a glance. J Cell Sci. 2017;130(21):3611–3617.
   PubMed Web of Science ®Google Scholar
• Ferraro F, Kriston-Vizi J, Metcalf DJ, et al. A two-tier golgi-based control of organelle size underpins the functional plasticity of endothelial cells. Dev Cell. 2014;29(3):292–304.
   PubMed Web of Science ®Google Scholar
• Swystun LL, Lillicrap D. Genetic regulation of plasma von Willebrand factor levels in health and disease. J Thromb Haemost. 2018;16(12):2375–2390.
   PubMed Web of Science ®Google Scholar
• Kalagara T, Moutsis T, Yang Y, et al. The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium. Blood Adv. 2018;2(18):2347–2357.
   PubMed Web of Science ®Google Scholar
• Rydz N, Swystun LL, Notley C, et al. The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels. Blood. 2013;121(26):5228–5237.
   PubMed Web of Science ®Google Scholar
• Schillemans M, Karampini E, Kat M, et al. Exocytosis of Weibel-Palade bodies: how to unpack a vascular emergency kit. J Thromb Haemost. 2019;17(1):6–18.
   PubMed Web of Science ®Google Scholar
• van Nispen tot Pannerden H, de Haas F, Geerts W, et al. The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes. Blood. 2010;116(7):1147–1156.
   PubMed Web of Science ®Google Scholar
• Winter WE, Greene DN, Beal SG, et al. Clotting factors: clinical biochemistry and their roles as plasma enzymes. Adv Clin Chem. 2020;94:31–84.
   PubMed Web of Science ®Google Scholar
• Fuller JR, Knockenhauer KE, Leksa NC, et al. Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy. Blood. 2021;137(21):2970–2980.
   PubMed Web of Science ®Google Scholar
• Xu ER, Emsley J. Factor VIII/VWF complex caught on camera. Blood. 2021;137(21):2865–2866.
   PubMed Web of Science ®Google Scholar
• Ward SE, O’Sullivan JM, O’Donnell JS. The relationship between ABO blood group, von Willebrand factor, and primary hemostasis. Blood. 2020;136(25):2864–2874.
   PubMed Web of Science ®Google Scholar
• Fu H, Jiang Y, Yang D, et al. Flow-induced elongation of von willebrand factor precedes tension-dependent activation. Nat Commun. 2017;8(1):324.
   PubMedGoogle Scholar
• Rana A, Westein E, Niego B, et al. Shear-dependent platelet aggregation: mechanisms and therapeutic opportunities. Front Cardiovasc Med. 2019;6:141.
   PubMed Web of Science ®Google Scholar
• Rosa JP, Raslova H, Bryckaert M. Filamin A: key actor in platelet biology. Blood. 2019;134(16):1279–1288.
   PubMed Web of Science ®Google Scholar
• Zhang W, Deng W, Zhou L, et al. Identification of a juxtamembrane mechanosensitive domain in the platelet mechanosensor glycoprotein Ib-IX complex. Blood. 2015;125(3):562–569.
   PubMed Web of Science ®Google Scholar
• Kasirer-Friede A, Cozzi MR, Mazzucato M, et al. Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors. Blood. 2004;103(9):3403–3411.
   PubMed Web of Science ®Google Scholar
• Haberichter SL, Balistreri M, Christopherson P, et al. Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival. Blood. 2006;108(10):3344–3351.
   PubMed Web of Science ®Google Scholar
• Sadler JE, Budde U, Eikenboom JC, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the subcommittee on von Willebrand factor. J Thromb Haemost. 2006;4(10):2103–2114.
   PubMed Web of Science ®Google Scholar
• Swystun LL, Lillicrap D. How much do we really know about von Willebrand disease? Curr Opin Hematol. 2016;23(5):471–478.
   PubMed Web of Science ®Google Scholar
• Lillicrap D. Von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Blood. 2013;122(23):3735–3740.
   PubMed Web of Science ®Google Scholar
• Leebeek FW, Eikenboom JC. Von willebrand’s disease. N Engl J Med. 2016;375(21):2067–2080.
   PubMed Web of Science ®Google Scholar
• NIBSC. SSC/ISTH secondary coagulation standard lot #5. NIBSC code: SSCLOT5. National Institute for Biological Standards and Control. Potters Bar, HRT. 2019. Available from: https://www.nibsc.org/documents/ifu/SSCLOT5.pdf
   Google Scholar
• Lavin M, O’Donnell JS. How I treat low von Willebrand factor levels. Blood. 2019;133(8):795–804.
   PubMed Web of Science ®Google Scholar
• Flood VH, Christopherson PA, Gill JC, et al. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States. Blood. 2016;127(20):2481–2488.
   PubMed Web of Science ®Google Scholar
• James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von willebrand disease. Blood Adv. 2021;5(1):280–300.
   PubMed Web of Science ®Google Scholar
• Rawley O, O'Sullivan JM, Chion A, et al. Von Willebrand factor arginine 1205 substitution results in accelerated macrophage-dependent clearance in vivo. J Thromb Haemost. 2015;13(5):821–826.
   PubMed Web of Science ®Google Scholar
• Casonato A, Galletta E, Sarolo L, et al. Type 2N von Willebrand disease: characterization and diagnostic difficulties. Haemophilia. 2018;24(1):134–140.
   PubMed Web of Science ®Google Scholar
• Seidizadeh O, Peyvandi F, Mannucci PM. Von Willebrand disease type 2N: an update. J Thromb Haemost. 2021;19(4):909–916.
   PubMed Web of Science ®Google Scholar
• Cuker A, Connors JM, Katz JT, et al. Clinical problem-solving. A bloody mystery. N Engl J Med. 2009;361(19):1887–1894.
   PubMedGoogle Scholar
• Makris M. Gastrointestinal bleeding in von willebrand disease. Thromb Res. 2006;118(1):S13–S1 7.
   PubMedGoogle Scholar
• Loscalzo J. From clinical observation to mechanism-Heyde’s syndrome. N Engl J Med. 2012;367(20):1954–1956.
   PubMed Web of Science ®Google Scholar
• Selvam S, James P. Angiodysplasia in von Willebrand disease: understanding the clinical and basic science. Semin Thromb Hemost. 2017;43(6):572–580.
   PubMed Web of Science ®Google Scholar
• Klarmann D, Eggert C, Geisen C, et al. Association of ABO(H) and I blood group system development with von Willebrand factor and factor VIII plasma levels in children and adolescents. Transfusion. 2010;50(7):1571–1580.
   PubMed Web of Science ®Google Scholar
• Miller CH, Dilley A, Richardson L, et al. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J Hematol. 2001;67(2):125–129.
   PubMed Web of Science ®Google Scholar
• Lipe BC, Dumas MA, Ornstein DL. Von Willebrand disease in pregnancy. Hematol Oncol Clin North Am. 2011;25(2):335–358, viii.
   PubMed Web of Science ®Google Scholar
• Favaloro EJ, Pasalic L, Curnow J. Laboratory tests used to help diagnose von Willebrand disease: an update. Pathology. 2016;48(4):303–318.
   PubMed Web of Science ®Google Scholar
• Favaloro EJ, Aboud M, Arthur C. Possibility of potential VWD misdiagnosis or misclassification using LIA technology and due to presence of rheumatoid factor. Am J Hematol. 2001;66(1):53–56.
   PubMed Web of Science ®Google Scholar
• Schlammadinger A, Vanhoorelbeke K, Laszlo P, et al. Von Willebrand factor antigen latex immunoassays are affected to a different extent by rheumatoid factor. Clin Appl Thromb Hemost. 2006;12(2):242–243.
   PubMed Web of Science ®Google Scholar
• Moser KA, Adcock Funk DM. Pitfalls in special coagulation testing: three illustrative case studies. Int J Lab Hematol. 2013;35(3):334–338.
   PubMed Web of Science ®Google Scholar
• Higgins RA, Goodwin AJ. Automated assays for von Willebrand factor activity. Am J Hematol. 2019;94(4):496–503.
   PubMed Web of Science ®Google Scholar
• Flood VH, Gill JC, Morateck PA, et al. Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor. Blood. 2010;116(2):280–286.
   PubMed Web of Science ®Google Scholar
• Vangenechten I, Mayger K, Smejkal P, et al. A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients. J Thromb Haemost. 2018;16(7):1268–1277.
   PubMed Web of Science ®Google Scholar
• Boender J, Eikenboom J, van der Bom JG, et al. Clinically relevant differences between assays for von Willebrand factor activity. J Thromb Haemost. 2018;16(12):2413–2424.
   PubMed Web of Science ®Google Scholar
• Timm A, Hillarp A, Philips M, et al. Comparison of automated von Willebrand factor activity assays. Thromb Res. 2015;135(4):684–691.
   PubMed Web of Science ®Google Scholar
• Chen D, Tange JI, Meyers BJ, et al. Validation of an automated latex particle-enhanced immunoturbidimetric von willebrand factor activity assay. J Thromb Haemost. 2011;9(10):1993–2002.
   PubMed Web of Science ®Google Scholar
• Fischer BE, Thomas KB, Schlokat U, et al. Triplet structure of human von willebrand factor. Biochem J. 1998;331(2):483–488.
   PubMedGoogle Scholar
• Furlan M, Robles R, Affolter D, et al. Triplet structure of von willebrand factor reflects proteolytic degradation of high molecular weight multimers. Proc Natl Acad Sci USA. 1993;90(16):7503–7507.
   PubMed Web of Science ®Google Scholar
• Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost. 1995;21(2):106–112.
   PubMedGoogle Scholar
• Favaloro EJ. Clinical utility of closure times using the platelet function analyzer-100/200. Am J Hematol. 2017;92(4):398–404.
   PubMed Web of Science ®Google Scholar